BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbe AG, Ludwar L, Scharfenberg I, Hellmich M, Dano R, Barbe MT, Noack MJ. Circadian rhythms and influencing factors of xerostomia among Parkinson’s disease patients. Oral Dis 2018;25:282-9. [DOI: 10.1111/odi.12942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Baram S, Karlsborg M, Øzhayat EB, Bakke M. Effect of orofacial physiotherapeutic and hygiene interventions on oral health-related quality of life in patients with Parkinson's disease: A randomised controlled trial. J Oral Rehabil 2021;48:1035-43. [PMID: 34129743 DOI: 10.1111/joor.13214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Umemoto G, Fujioka S, Iwasa Y, Ozaki Y, Koga K, Nishimura K, Tsuboi Y. Impact of Progression of Parkinson's Disease on Swallowing Ability and Oral Environment. Parkinsons Dis 2021;2021:5571556. [PMID: 33981405 DOI: 10.1155/2021/5571556] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Rascol O, Negre-pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-lloret S; for the COPARK Study Group. Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort. J Neural Transm 2020;127:1607-17. [DOI: 10.1007/s00702-020-02249-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 McNaney R, Miller N, Vines J, Olivier P, Ladha K, Jackson D, Walker R. The feasibility and acceptability of using a novel wrist worn cueing device to self-manage drooling problems in people with Parkinson's disease: A pilot study. J Rehabil Assist Technol Eng 2019;6:2055668319852529. [PMID: 31662884 DOI: 10.1177/2055668319852529] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wollmer E, Klein S. A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson’s disease. International Journal of Pharmaceutics 2017;533:298-314. [DOI: 10.1016/j.ijpharm.2017.08.126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]